Stay updated on Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.

Latest updates to the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now shows a new site revision (v3.7.0) replacing the previous v3.6.6, indicating a technical update to the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check36 days agoChange DetectedThe revision tag in the study record history was updated to v3.6.6, signaling a newer version of the page. It is a metadata update and does not alter the trial data or displayed content.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision tag (v3.6.5) was added to the history. The References section and the previous revision (v3.6.4) were removed.SummaryDifference0.1%

- Check72 days agoChange DetectedThe record history now shows a new latest revision labeled v3.6.4, updating the page from the previous v3.6.3; this reflects a maintenance/versioning update rather than changes to study content.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, signaling a newer version of the page. This metadata change does not modify study data or user-facing content beyond the version label.SummaryDifference0.0%

- Check100 days agoChange DetectedA new site revision (v3.6.2) was added to the record history and the previous revision (v3.6.0) was removed, reflecting a platform update in the page history.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in MSI-H/dMMR Stage IV CRC Clinical Trial page.